Arax Advisory Partners’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$60.5K Buy
1,279
+1,026
+406% +$52.7K ﹤0.01% 3118
2026
Q1
$13.5K Sell
253
-48
-16% -$3.11K ﹤0.01% 2291
2025
Q4
$18.6K Sell
301
-219
-42% -$13.4K ﹤0.01% 2154
2025
Q3
$32.4K Buy
520
+257
+98% +$17.9K ﹤0.01% 2047
2025
Q2
$21K Sell
263
-2
-0.8% -$167 ﹤0.01% 1642
2025
Q1
$22.8K Buy
265
+74
+39% +$6.07K ﹤0.01% 1248
2024
Q4
$14.9K Buy
191
+25
+15% +$1.94K ﹤0.01% 1330
2024
Q3
$12K Hold
166
﹤0.01% 1328
2024
Q2
$11.4K Buy
+166
New +$11.2K ﹤0.01% 1202

Other funds holding PBH

Arax Advisory Partners's PBH Position: Q2 2026 in Review

Arax Advisory Partners increased its Prestige Consumer Healthcare (PBH) stake by 406% in Q2 2026, buying an estimated $52.7K and bringing the position to 1,279 shares worth $60.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3118.

Arax Advisory Partners first reported a position in PBH in Q2 2024 and has held it in 9 quarters since. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Arax Advisory Partners held 1,279 shares of Prestige Consumer Healthcare worth $60.5K as of Q2 2026.
  • Arax Advisory Partners bought 1,026 Prestige Consumer Healthcare shares in Q2 2026, an estimated $52.7K.
  • Prestige Consumer Healthcare made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3118 holding.
  • Arax Advisory Partners first reported a position in Prestige Consumer Healthcare in Q2 2024 and has held it in 9 quarters since.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.